Skip to main content

Biotech Companies Invest Microfluidic Device Development for Pathogen Detection

 Emerging COVID-19 variants have encouraged many biotech giants to actively participate in developing microfluidic devices for rapid and accurate SARS-CoV-2 detection.

 

Though the current global wave of the omicron COVID-19 variant is relatively mild in terms of causing severe disease and death, it's necessary to continuously develop new technologies and strategies to identify and resist COVID-19 infection in case more aggressive variants may come around from nowhere. Microfluidics, a highly miniaturized, automatic, and integrated technology, is expected to perform rapid, low-cost, accurate, and point-of-care detection of infectious diseases like COVID-19. Researchers from leading life science companies like Creative Biolabs have gotten involved in developing and designing microfluidic devices for different applications, including devices for quick and accurate SARS-CoV-2 detection.

 

Microfluidic Chips for Pathogen Detection

 

Infectious diseases arise from pathogens, including bacteria, viruses, and parasites, with global distribution and transmission between individuals. Scientists have developed some disposable microfluidic chips that can detect pathogens simply with drops of biological fluids, such as saliva, blood, sweat, and urine. For instance, a microfluidic chip can accurately detect the SARS-CoV-2 virus with a few drops of saliva with fluorescent antibodies against the virus, whose accuracy could be comparable to the gold-standard test, PCR.

 

Besides the SARS-CoV-2 virus, the microfluidic chips are versatile in manipulating and detecting many other pathogens, including seasonal coronavirus, HIV, influenza viruses, the Zika virus, H1N1 influenza virus, and even microorganisms like Legionella and E. coli. Moreover, microfluidic chips have also been combined with traditional methods like PCR, RT-PCR, qPCR, RT-LAMP due to simplicity in function and fabrication, rapid turnaround time, decreased reagent consumption, reduced contamination, etc.

 

Driven by the rapid advancements of technology, digital microfluidic devices for molecular diagnostics have become attractive and promising tools to deal with the severe COVID-19 pandemic as well as diseases caused by other pathogens.

 

The increasing need of adopting cutting-edge microfluidic-based tools has encouraged life science companies like Creative Biolabs to be dedicated to providing one-stop solutions to microfluidic chip development and design, especially microfluidic chips for tumor marker detection, viruses detection, and fungal infections. Several automatic and portable microfluidic platforms have been established for single-cell analyses, molecular diagnostics, DNA sequencing, PCR amplification, amino acid/peptide/protein analysis, immunoassays, cell sorting, manipulation, and so on.

 

About the Author

 

Vivian is a biotechnology beat reporter exploring the cutting edge of microfluidic analysis. To find out more about microfluidic chips, click here.

Labels:

Comments

Post a Comment

Popular posts from this blog

Everything You Want to Know About Antibody Development

  Everything You Want to Know About Antibody Development   When foreign molecules, which are known as antigens, enter our body, antibodies will be released by B cells of the immune system to specifically bind to the antigens and finally clear out those “invaders”. Such a highly specific molecular recognition mechanism has inspired a variety of antibody development research and diagnostic applications nowadays, including IVD antibody development .   What is Antibody Development?   Antibody development is the process of creating and characterizing an antibody.   The timeline of developing antibodies starts from the injection of an antigen of interest into a host animal, so that the host’s immune system can detect it and generat e  the desired antibodies. Then, antibody development proceeds with finding and isolating the desired antibodies from the rest of the protein in sera.   The reset procedure of antibody development is varied as the desired antibodi...
Post a Comment
Read more

An Overview of the Global Bispecific Antibody Therapeutics Market

  Antibod ies , a major component of adaptive immunity, play a critical role in protective and pathogenic immune responses. In r ecent years, a wide range of antibodies is discovered as candidates of cancer therapeutic agents, including the reconstructive molecules, bispecific antibodies (BsAbs).   About Bispecific Antibody   Bispecific antibodies, as its name indicates, consists of two antigen-binding sites, which can simultaneously bind two separate and unique antigens (or different epitopes of the same antigen). This structure is  typically designed to bind to two targets, one on a cancer cell and one on an immune cell, act ivating or redirecting immune effector cells with the goal of getting the immune cell to kill the cancer cell by antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC) and other cytotoxic mechanisms.   U nique biological and pharmacological properties, ...
Post a Comment
Read more

Unmodified Bacteriophages Research Updates

  R ecent research conducted by researchers from Yale University is published in  Applied and Environmental Microbiology , suggesting  that natural bacteriophage, or phage, can kill dysentery-causing bacteria and reduce virulence in surviving bacteria. It's a piece   of  inspiring news as  treating dysentery has become a challenge with the rising antibiotic resistance.   Background   Shigella flexneri , the culprit causing contagious infection marked by inflammatory diarrhea and dysentery in sub-Saharan Africa and southern Asia, kills about 160,000 people globally every year. The World Health Organization (WHO) takes priority to this pathogen in terms of increasing cases, antimicrobial resistance, and limited treatment options.   S. flexneri  is active primarily in low-income countries, like southern Asia and sub-Saharan Africa. In these places, dirty drinking water is a concern causing dysentery, while antibiotics are expensive and unav...
Post a Comment
Read more